Watch Ticker

Esperion Therapeutics, Inc.

Go to Esperion Therapeutics, Inc. Website

$1.49

0.00 (0.00%)

Live

Previous Close

$1.49

Day Range

$0 - $0

Previous Day Range

$1.38 - $1.52

Market Cap

$277.5 million USD

Day Vol.

Previous Day Vol.

4.5 million

Currency

USD

Primary Exchange

Nasdaq

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

Esperion, a commercial-stage biopharmaceutical company, announced its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025. The company will provide a live webcast of the event on its investor and media section.

Related tickers: ESPR.

Read Full Article

N/A - Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025

Esperion announced new research supporting its lead development candidates for the treatment of primary sclerosing cholangitis (PSC), a rare and progressive liver disease. The company's next-generation ACLY inhibitor discovery program has shown promising preclinical results in reducing liver injury, inflammation, and fibrosis.

Related tickers: ESPR.

Read Full Article

Trending Tickers

Please sign in to view